Experienced in Erythema Multiforme

Emmanuella Guenova

Lausanne, VD, CH 
Experienced in Erythema Multiforme
Lausanne, VD, CH 
OverviewLocationsClinical Research

Overview

Emmanuella Guenova practices in Lausanne, Switzerland. Ms. Guenova is rated as an Experienced expert by MediFind in the treatment of Erythema Multiforme. Her top areas of expertise are Cutaneous T-Cell Lymphoma (CTCL), Mycosis Fungoides, T-Cell Lymphoma, Non-Hodgkin Lymphoma, and Bone Marrow Transplant.

Her clinical research consists of co-authoring 220 peer reviewed articles and participating in 2 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, she has co-authored 4 articles in the study of Erythema Multiforme.

Gender
Female

Locations

Lausanne, VD 1011, Switzerland
Other Locations
Zurich, ZH, Switzerland
Kantonsspital St Gallen, St Gallen
Switzerland
Cantonal Hospital St. Gallen
Sankt Gallen, SG, Switzerland

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

Phase II Trial of Atezolizumab (Anti-PD-L1) in the Treatment of Stage IIb-IV Mycosis Fungoides/Sezary Syndrome Patients Relapsed/Refractory After a Previous Systemic Treatment
Phase II Trial of Atezolizumab (Anti-PD-L1) in the Treatment of Stage IIb-IV Mycosis Fungoides/Sezary Syndrome Patients Relapsed/Refractory After a Previous Systemic Treatment
Enrollment Status: Terminated
Publish Date: February 22, 2024
Intervention Type: Drug
Study Drug: Atezolizumab
Study Phase: Phase 2
A Prospective, Multicenter, Single-Arm Cohort Study of Photopheresis in the Treatment of Erythrodermic MF and SS
A Prospective, Multicenter, Single-Arm Cohort Study of Photopheresis in the Treatment of Erythrodermic MF and SS
Enrollment Status: Withdrawn
Publish Date: September 08, 2021
Intervention Type: Device, Drug
Study Phase: Phase 2
View 1 Less Clinical Trial

220 Total Publications

Anti-p200 pemphigoid with autoantibodies targeting laminin beta-4 and clinical response to methotrexate.
Anti-p200 pemphigoid with autoantibodies targeting laminin beta-4 and clinical response to methotrexate.
Journal: JAAD case reports
Published: September 11, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Ms. Guenova's expertise for a condition
ConditionClose
View All 11 Advanced Conditions
View All 56 Experienced Conditions
Want to save this expert for later?
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile